Jiangsu Nanfang Medical (603880.SH) announced on June 24th that, according to the relevant regulations of the Shanghai Stock Exchange Listing Rules, the company's stock will be suspended for one day from June 25th, 2024. The stock will resume trading on June 26th, 2024 and the other risk warnings will be revoked. After the revocation of other risk warnings, the company's stocks will be traded on the risk warning board, and the stock abbreviation will be changed from "ST Nanwei" to "Nanwei shares". The daily limit of the company's stock price fluctuation will be changed from 5% to 10%, and the stock code will remain 603880.
ST南卫(603880.SH)：撤销其他风险警示暨停牌
Jiangsu Nanfang Medical (603880.SH): Revocation of other risk warnings and suspension
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.